论文部分内容阅读
背景:临床试验报道的经皮冠状动脉介入(PCI)对ST段抬高型心肌梗死(STEMI)患者的良好效果能否在日常医疗实践中得以重复,尤其是该操作是否优于院前溶栓(PHT)治疗这一问题已受到质疑。目的:评价不同再灌注策略治疗连续STEMI患者的结果。
BACKGROUND: Is clinical efficacy of percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) reported in clinical trials repeatable in routine medical practice, especially if this procedure is superior to pre-hospital thrombolysis (PHT) treatment of this issue has been questioned. OBJECTIVE: To evaluate the outcomes of different reperfusion strategies in patients with consecutive STEMI.